08048036315
Leading exporter of Genuine SANDOSTATIN LAR 30MG  INJ from India to Singapore -Tampines|Phoenix Exim

1. General Information

Sandostatin LAR 30 mg is a long-acting formulation of octreotide belonging to the somatostatin analogue class. It is used mainly for the long-term management of conditions in which excessive secretion of certain hormones or gastrointestinal peptides occurs.

In the U.S., Sandostatin LAR Depot is indicated for appropriately selected patients with acromegaly, severe diarrhea/flushing associated with metastatic carcinoid tumors, and profuse watery diarrhea associated with VIP-secreting tumors.

2. Product Information

ProductSandostatin LAR 30 mg Injection
Active ingredientOctreotide acetate
Strength30 mg/vial
Drug classSomatostatin analogue
Dosage formLong-acting injectable suspension
RouteDeep intramuscular/gluteal injection
Manufacturer/brandSandostatin LAR – Novartis
Prescription statusPrescription medicine
ATC codeH01CB02

The product is supplied as a powder requiring reconstitution with the supplied diluent before administration. It is intended for deep intragluteal/intramuscular administration by a healthcare professional, not for self-injection.

3. Uses of Sandostatin LAR 30 mg

Sandostatin LAR may be prescribed for:

  • Acromegaly, particularly when surgery or radiotherapy is inadequate, inappropriate or not an option.
  • Control of severe diarrhea and flushing associated with metastatic carcinoid tumors.
  • Control of profuse watery diarrhea associated with VIP-secreting tumors (VIPomas).
  • In some countries, additional indications involving specific neuroendocrine tumors may be approved according to local product information.

4. Benefits of This Medicine

Under appropriate medical supervision, octreotide may:

  • Help reduce excessive growth hormone (GH) secretion in acromegaly.
  • Help lower IGF-1 levels toward the desired range.
  • Reduce symptoms associated with excessive hormone secretion.
  • Help control severe diarrhea and flushing associated with certain neuroendocrine tumors.
  • Provide prolonged drug exposure because the LAR formulation is designed for administration at extended intervals.

The medicine controls symptoms and hormone secretion; it should not be assumed to eliminate or cure an underlying tumor. In carcinoid syndrome and VIPomas, the U.S. prescribing information notes that its effect on tumor size, tumor growth or metastasis development has not been established.

5. Side Effects of Sandostatin LAR 30 mg

Possible adverse effects include:

  • Diarrhea or constipation
  • Abdominal pain or discomfort
  • Nausea
  • Flatulence
  • Headache
  • Injection-site reactions
  • Gallstones or other gallbladder problems
  • Changes in blood glucose
  • Dizziness
  • Fatigue
  • Changes in thyroid function
  • Slow heart rate (bradycardia)

Less common or potentially serious reactions can include pancreatitis, significant gallbladder complications, heart rhythm abnormalities and allergic/hypersensitivity reactions.

6. Common Side Effects

Frequently reported effects include:

  • Diarrhea
  • Abdominal pain
  • Nausea
  • Flatulence
  • Headache
  • Gallstones (cholelithiasis)
  • Injection-site pain or reactions
  • Changes in blood glucose

The exact frequency varies according to the condition being treated and patient population. The current U.S. label reports diarrhea, cholelithiasis, abdominal pain and flatulence among the most common reactions in patients treated for acromegaly.

7. How to Use Sandostatin LAR 30 mg

Sandostatin LAR should be prepared and administered by a qualified healthcare professional.

The dose and interval depend on the patient's condition, previous response to short-acting Sandostatin, laboratory results and clinical response. The U.S. labeling generally uses administration at 4-week intervals, but the 30 mg strength is not automatically the starting dose for every patient.

The injection is given deep into the gluteal muscle, with injection sites alternated between the left and right buttock.

Do not attempt to reconstitute or inject this medicine yourself unless specifically trained and instructed by a healthcare professional.

8. How Sandostatin LAR Works

Octreotide is a synthetic analogue of somatostatin. It acts on somatostatin receptors and suppresses the release of several hormones and gastrointestinal peptides.

In acromegaly, it particularly reduces excessive growth hormone secretion, which can subsequently reduce IGF-1 levels. It can also inhibit secretion of substances such as serotonin and other peptides involved in symptoms of certain neuroendocrine tumors.

The LAR formulation uses a long-acting delivery system that releases octreotide gradually, allowing treatment at longer intervals than short-acting octreotide injections.

9. Safety Advice

  • Use only under the supervision of a qualified healthcare professional.
  • Inform your doctor if you have gallstones or gallbladder disease.
  • Blood glucose may increase or decrease, so patients with diabetes may require monitoring and adjustment of antidiabetic therapy.
  • Thyroid function may need periodic monitoring.
  • Tell your doctor about heart problems because octreotide can cause bradycardia or other cardiac conduction/rhythm abnormalities.
  • Report persistent abdominal pain, severe diarrhea, jaundice, unusual stool changes or significant weight loss.
  • Inform your healthcare provider about all medicines you take, including insulin, oral diabetes medicines, beta-blockers, cyclosporine and bromocriptine, because interactions or dose adjustments may be necessary.
  • The product should be stored according to its official labeling. U.S. packaging information specifies refrigeration at 2°C–8°C (36°F–46°F) and protection from light.
  • Pregnancy and breastfeeding decisions should be discussed with a healthcare professional.

10. FAQs

Q1. What is Sandostatin LAR 30 mg used for?
It is used for certain hormone-related disorders, including acromegaly and specific symptoms associated with carcinoid tumors and VIP-secreting tumors.

Q2. What is the active ingredient?
The active ingredient is octreotide, supplied as octreotide acetate.

Q3. Is Sandostatin LAR 30 mg a tablet?
No. It is a long-acting injectable suspension supplied in a vial.

Q4. How often is Sandostatin LAR given?
It is commonly administered at 4-week intervals, but the exact regimen must be determined by the treating physician.

Q5. Can I inject Sandostatin LAR myself?
It should be administered by a trained healthcare professional because it requires appropriate reconstitution and deep intramuscular administration.

Q6. Can Sandostatin LAR cure acromegaly?
It helps control excessive GH/IGF-1 activity and symptoms but is not generally described as a cure.

Q7. Does Sandostatin LAR cause gallstones?
Gallstones and other gallbladder abnormalities can occur during octreotide treatment, particularly with long-term therapy.

Q8. Does Sandostatin LAR affect blood sugar?
Yes. It can cause either hyperglycemia or hypoglycemia, so glucose monitoring may be required.

Q9. Is Sandostatin LAR prescription-only?
Yes. It is a prescription medicine and should be used only under medical supervision.

Q10. Is 30 mg suitable for every patient?
No. The appropriate strength depends on the indication, previous treatment, response and physician's assessment.

11. Substitutes / Alternatives

The most appropriate substitute depends on the indication, dose, formulation and patient's previous response. Possible therapeutic alternatives may include:

  • Octreotide immediate-release injection – same active medicine in a shorter-acting formulation.
  • Lanreotide depot injection – another long-acting somatostatin analogue used for certain indications, including acromegaly.
  • Other disease-specific treatments may be considered depending on whether the patient has acromegaly or a neuroendocrine tumor.

A substitute should not be selected solely on the basis of the same therapeutic class. The treating specialist should determine the appropriate alternative and dose.

12. SEO & B2B Keywords

Primary Keywords:

  • Sandostatin LAR 30 mg Injection
  • Sandostatin LAR 30 mg
  • Sandostatin 30 mg Injection
  • Octreotide 30 mg Injection
  • Octreotide acetate injection
  • Sandostatin LAR supplier
  • Sandostatin LAR exporter from India
  • Sandostatin LAR pharmaceutical exporter
  • Sandostatin LAR medicine supplier
  • Sandostatin LAR 30 mg manufacturer

Long-Tail B2B Keywords:

  • Buy Sandostatin LAR 30 mg Injection from India
  • Sandostatin LAR 30 mg pharmaceutical exporter from Nagpur India
  • Sandostatin LAR 30 mg wholesale supplier India
  • Octreotide 30 mg injection exporter from India
  • Sandostatin LAR 30 mg international medicine supplier
  • Sandostatin LAR 30 mg wholesale pharmaceutical supplier
  • Sandostatin LAR 30 mg supplier for USA
  • Sandostatin LAR 30 mg supplier for UK
  • Sandostatin LAR 30 mg supplier for Australia
  • Sandostatin LAR 30 mg supplier for Canada
  • Sandostatin LAR 30 mg supplier for Singapore
  • Sandostatin LAR 30 mg supplier for South Korea
  • Sandostatin LAR 30 mg supplier for UAE
  • Octreotide injection exporter from Nagpur India
  • Sandostatin LAR 30 mg B2B pharmaceutical supplier
Aug 19th, 2026 3:57 PM

Keywords